PoliticsT2 · Outlet report
Lilly, Novo to Lower Obesity Drug Prices in Trump Deal
Eli Lilly and Novo Nordisk, two major pharmaceutical companies, have reached an agreement with the Trump administration to lower the prices of their obesity drugs, Zepbound and…
3 updates1 source1 mention here
Nov 6, 2025
Latest: U.S. Announces Negotiated Prices for 15 Drugs Under Medicare · NYT
